CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy

DNA Hypomethylating Drugs in Cancer Therapy

(2017) Takahiro Sato et al.   Cold Spring Harbor Perspectives in Medicine

OASIS/CREB3L1is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migrationin vitro

(2015) Michael Rose et al.   Epigenetics

Identification of CREB3L1 as a Biomarker Predicting Doxorubicin Treatment Outcome

(2015) Bray Denard et al.   PLoS One

Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue – a review

(2014) Nickolay Fedchenko et al.   Diagnostic Pathology

Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis

(2013) Renske DM Steenbergen et al.   JOURNAL OF PATHOLOGY

Epigenetic Silencing of Antiviral Genes Renders Clones of Huh-7 Cells Permissive for Hepatitis C Virus Replication

(2012) Q. Chen et al.   JOURNAL OF VIROLOGY

A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma

(2012) S. Sivanand et al.   Science Translational Medicine

How does doxorubicin work?

(2012) Anand G Patel et al.   eLife

Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1

(2012) Bray Denard et al.   eLife

Hormone Receptor Status Rather Than HER2 Status Is Significantly Associated With Increased Ki-67 and p53 Expression in Triple-Negative Breast Carcinomas, and High Expression of Ki-67 but Not p53 Is Significantly Associated With Axillary Nodal Metastasis in Triple-Negative and High-Grade Non–Triple-Negative Breast Carcinomas

(2011) Jeong S. Han et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

The Membrane-Bound Transcription Factor CREB3L1 Is Activated in Response to Virus Infection to Inhibit Proliferation of Virus-Infected Cells

(2011) Bray Denard et al.   Cell Host & Microbe

Doxorubicin Cardiomyopathy

(2009) Kanu Chatterjee et al.   CARDIOLOGY

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

(2008) Cornelia Liedtke et al.   JOURNAL OF CLINICAL ONCOLOGY